Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05381025 · ClinicalTrials.gov registry record · NA
Kavalactones on Sleep and Cortisol in Healthy Special Forces Trainees
A NA study of Sleep, sponsored by Thorne HealthTech.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05381025: Completed NA study of Sleep, sponsored by Thorne HealthTech.
NCT05381025 is a NA study of Sleep that has completed, run by Thorne HealthTech. The registered enrollment target is 15 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05381025, a NA study of Sleep, has completed, sponsored by Thorne HealthTech.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being done to better understand the effects of kava supplementation on sleep quality and salivary cortisol in the context of the acute physical and psychological stress of military special forces preparation training. Kava is a botanical dietary supplement derived from the plant Piper methysticum. Cortisol is a hormone associated with stress.
Primary Outcome
Diurnal salivary samples will be collected and tested for cortisol levels \[ng/ml\].
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Kava (Piper methysticum) extract
Study Locations (1)
Virginia
- Performance First - Virginia Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2022-10-09 |
| Phase | NA |
What the finished NCT05381025 record still lists
NCT05381025 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Kava (Piper methysticum) extract is the first listed.
NCT05381025 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05381025 about?
NCT05381025 is a clinical study titled "Kavalactones on Sleep and Cortisol in Healthy Special Forces Trainees". This research study is being done to better understand the effects of kava supplementation on sleep quality and salivary cortisol in the context of the acute physical and psychological stress of military special forces preparation training. Kava is a botanical dietary supplement derived from the pla...
What is the current status of trial NCT05381025?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-05-11. Estimated completion is 2022-10-09.
What conditions does trial NCT05381025 study?
This clinical trial studies the following conditions: Sleep.
What interventions are being tested in trial NCT05381025?
The interventions under investigation include: Kava (Piper methysticum) extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05381025?
This trial is sponsored by Thorne HealthTech, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05381025 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05381025's enrollment target sits among peer trials
15 143rd of 151 higher than 8 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI